T.M. v. University of Maryland Medical System Corporation

CourtDistrict Court, D. Maryland
DecidedJuly 23, 2024
Docket1:23-cv-01684
StatusUnknown

This text of T.M. v. University of Maryland Medical System Corporation (T.M. v. University of Maryland Medical System Corporation) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
T.M. v. University of Maryland Medical System Corporation, (D. Md. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

* T.M. et al., * * Plaintiffs, * * Civil Case No.: SAG-23-01684 v. * * UNIVERSITY OF MARYLAND * MEDICAL SYSTEM * CORPORATION et al., * * Defendants. * * * * * * * * * * * * MEMORANDUM OPINION

Plaintiff T.M., alongside her parents, J.M. and A.M. (collectively, “Plaintiffs”), bring this action against University of Maryland Medical System Corporation (“UMMSC”), the Baltimore Washington Medical Center (“BWMC”), and two individuals (collectively, “Defendants”),1 alleging that a state court consent order violates T.M.’s federal and state constitutional rights and should be void and unenforceable. ECF 1. Defendants have filed a motion to dismiss, ECF 40, which Plaintiffs opposed, ECF 47. Defendants then filed a reply, ECF 65, to which Plaintiffs filed a surreply, ECF 72. The Court has carefully reviewed the filings and finds that no hearing is necessary. See Loc. R. 105.6 (D. Md. 2023). For the reasons explained below, Defendants’ motion to dismiss will be GRANTED with prejudice as to T.M.’s claims and without prejudice as to J.M.’s and A.M.’s claims.

1 Plaintiffs also brought this action against Anne Arundel County and Be-Live-It Therapy LLC. On January 22, 2024, the Court dismissed Anne Arundel County from this action. ECF 64. On April 26, 2024, the Clerk of Court entered default as to Be-Live-It Therapy LLC. ECF 76. I. BACKGROUND The facts described herein are derived from Plaintiffs’ Complaint and are taken as true for purposes of this motion. T.M. has been diagnosed with Hashimoto’s Thyroiditis and Non-Celiac Gluten Sensitivity, which causes changes to her mental status when she ingests any amount of

gluten. ECF 1 ¶ 28. On March 23, 2023, T.M. accidentally ingested gluten, triggering a psychotic episode that resulted in a police escort to BWMC. Id. ¶¶ 41–42. Despite a request for voluntary admission, T.M. was involuntarily admitted to BWMC after an administrative hearing on April 11, 2023. Id. ¶¶ 57–58, 61, 63. During the administrative hearing, an administrative law judge heard testimony from Dr. Thomas Cummings, Jr., M.D., who treated T.M. at BWMC and opined that T.M. was “very impaired cognitively,” and that T.M.’s father, J.M., was coercing his daughter to request voluntary admission. Id. ¶¶ 64–65. Following the administrative hearing, Dr. Cummings and BWMC scheduled a clinic review panel and obtained a panel order to forcibly inject T.M. with antipsychotic medications. Id. ¶ 78. T.M. immediately appealed the panel order and another administrative hearing was scheduled for April 25, 2023. Id. ¶ 81. But before that hearing,

Defendants voluntarily withdrew their request for forcible injections because T.M. commenced ingesting medications after the clinic review panel. Id. ¶ 84. Nonetheless, on April 24, 2023, Dr. Cummings attempted to inject T.M. Id. ¶¶ 86, 88. When T.M. refused, Dr. Cummings re-scheduled a clinic review panel for April 27, 2023. Id. ¶ 89–90. The panel affirmed Dr. Cummings’s renewed request for forcible injection, which T.M. then appealed. Id. ¶¶ 104, 111. At another hearing on May 2, 2023, Dr. Cummings testified that forcible injection was necessary because T.M. was unwilling to orally ingest her medications and was unwilling to shower. Id. ¶¶ 115, 124. The administrative law judge affirmed the panel’s finding, determining that BWMC complied with statutory requirements for requesting and imposing forcible injections. Id. ¶ 128. On May 24, 2023, Dr. Erik Messamore, a psychiatric physician and professor of psychiatry, remotely interviewed T.M. and described her general appearance and behavior in the interview as

“pleasant and cooperative” with no evidence of psychosis. Id. ¶¶ 157, 160; ECF 2 at 4–5. After the interview and upon his review of T.M.’s recent hospitalization records, Dr. Messamore opined that T.M.’s condition markedly improved and did not “fulfill criteria for inpatient care.” ECF 2 at 7; ECF 1 ¶ 164. Dr. Messamore’s findings were corroborated by another psychiatrist who personally observed T.M. on April 21, 2023, and May 1, 2023, and concluded that she “no longer appeared actively psychotic.” ECF 1 ¶¶ 167–69; ECF 2-15. T.M. soon thereafter filed lawsuits in state and federal court in an effort to secure her release from BWMC. One of the federal lawsuits, filed in this Court, alleged that Defendants were unlawfully detaining T.M. against her will, and it sought an emergency motion for a temporary restraining order. See Emergency Mot. for TRO and Prelim. Inj., Doe v. Univ. of Md. Med. Sys.

Corp., Civ. No. SAG-23-1572 (D. Md. June 9, 2023). This Court scheduled a hearing on the emergency motion on June 13, 2023, but immediately prior to the hearing, the parties reached a Consent Order in a simultaneous habeas action in state court, resolving their dispute. See ECF 2- 1. T.M. then moved to cancel the June 13, 2023, hearing and later dismissed the initial federal action. See Notice of Dismissal with Prejudice, Doe v. Univ. of Md. Med. Sys. Corp., Civ. No. SAG-23-1572 (D. Md. June 26, 2023). The state court Consent Order provided for T.M.’s immediate release from BWMC subject to various conditions, including that she (1) obtain a new treating psychiatrist and continue to take her hospital-prescribed medications; (2) regularly meet and consult with a third-party provider regarding her treatment and medication; (3) accept a referral to the Anne Arundel Crisis Intervention Team (“AACIT”) and follow their recommendations; (4) take all prescribed medications; and (5) dismiss with prejudice all of her pending actions against UMMSC, BWMC, and their employees. ECF 2-1. The Consent Order also ordered that J.M. and A.M. (1) monitor

and remind T.M. of her obligations to take her prescribed medications; (2) immediately notify the AACIT and the third-party provider if she did not comply with her medication obligations; and (3) dismiss with prejudice their pending actions against BWMC, UMMSC, its employees and its attorneys. Id. A state court judge and five attorneys representing T.M. signed the Consent Order. Id. T.M. was then released from BWMC. II. PROCEDURAL HISTORY Just ten days later, with entirely different counsel, T.M., along with A.M. and J.M., commenced this second federal action on June 22, 2023, alleging that the Consent Order had been entered under duress and violated the Maryland Declaration of Rights and the Due Process Clause of the Fourteenth Amendment. ECF 1 ¶¶ 188–99. Plaintiffs seek a declaratory judgment that the

Consent Order is unconstitutional and unenforceable and request injunctive relief against its enforcement. Id. at 39. Initially, this Court questioned its jurisdiction to rule on the validity of a state court Consent Order and ordered briefing from the parties explaining why the instant case was properly in federal court. ECF 10. Plaintiffs defended jurisdiction by asserting that neither the Rooker-Feldman doctrine nor any doctrine of abstention applied, ECF 17, but before the Court issued its ruling on jurisdiction, it became aware that T.M. also appealed the state court Consent Order to the Appellate Court of Maryland on June 28, 2023, ECF 21; see ECF 17 at 8 n.5. In light of the seemingly identical issues raised in the state court appeal, the Court ordered and received additional briefing on relevant abstention doctrines. ECF 24, 25, 26. After review, the Court concluded that abstention was inappropriate, ECF 27, but made no explicit findings with respect to the Rooker-Feldman doctrine. The Court then proceeded to consider Plaintiffs’ motion for a temporary restraining order, ECF 6, eventually denying it at a hearing on September 5, 2023, ECF 34. Defendants then filed the instant motion to dismiss on October 23, 2023. ECF 40.

Unbeknownst to this Court, on October 31, 2023, T.M.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hertz Corp. v. Friend
559 U.S. 77 (Supreme Court, 2010)
Rooker v. Fidelity Trust Co.
263 U.S. 413 (Supreme Court, 1924)
District of Columbia Court of Appeals v. Feldman
460 U.S. 462 (Supreme Court, 1983)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Johnson v. De Grandy
512 U.S. 997 (Supreme Court, 1994)
Exxon Mobil Corp. v. Saudi Basic Industries Corp.
544 U.S. 280 (Supreme Court, 2005)
Lance v. Dennis
546 U.S. 459 (Supreme Court, 2006)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
A Society Without a Name v. Commonwealth of Virginia
655 F.3d 342 (Fourth Circuit, 2011)
Painter's Mill Grille, LLC v. Howard Brown
716 F.3d 342 (Fourth Circuit, 2013)
Willner v. Frey
243 F. App'x 744 (Fourth Circuit, 2007)
Johnson v. Orr
551 F.3d 564 (Seventh Circuit, 2008)
Zachair, Ltd. v. Driggs
965 F. Supp. 741 (D. Maryland, 1997)
Field Auto City, Inc. v. General Motors Corp.
476 F. Supp. 2d 545 (E.D. Virginia, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
T.M. v. University of Maryland Medical System Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tm-v-university-of-maryland-medical-system-corporation-mdd-2024.